Aktuell 21 nov 2023 CRISPR Therapeutics und Vertex erhalten historische Zulassung Die Partner CRISPR Therapeutics und Vertex haben in Grossbritannien die weltweit erste Zulassung einer Therapie erreicht, die auf Genom-Editie...
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 out 2024–24 out 2024 Malham Arábia Saudita
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 out 2024–24 out 2024 Malham Arábia Saudita
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 out 2024–24 out 2024 Malham Arábia Saudita
News 21 nov 2023 CRISPR Therapeutics and Vertex awarded historic authorization The two partners CRISPR Therapeutics and Vertex have secured the world’s first approval for a genome editing therapy based on what are known as g...
Mini SWISS Pavilion mini SWISS Pavilion @ Global Health Exhibition 2024 22 out 2024–24 out 2024 Malham Arábia Saudita
News 24 jan 2024 Odne secures fifth investment from the Dental Innovation Alliance The North American venture capital firm Dental Innovation Alliance has made a fifth investment in Odne. This will support the market launch of an...
Actualités 11 out 2023 Lonza élargit davantage ses capacités de fabrication d’ADC à Viège Lonza amplifie sa production d’ADC via une extension importante de la capacité de bioconjugaison de son Ibex Dedicate Biopark à Viège, ce qui dev...
News 27 out 2023 Roche uses artificial intelligence for cancer diagnosis Roche is teaming up with Ibex Medical Analytics and Amazon Web Services in the field of artificial intelligence (AI). The goal is to help patholo...
News 06 out 2022 Switzerland still the most innovative economy in the world For the twelfth time in a row, Switzerland is the most innovative economy in the world. This is according to the Global Innovation Index, which l...
News 02 nov 2023 Four innovative Geneva start-ups receive FIF support Geneva's FIF has backed four promising start-ups, fostering innovation in line with the UN's Sustainable Development Goals.